Log in

Pivot Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:PVOTF)

0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
Now: $0.13
50-Day Range
MA: $0.21
52-Week Range
Now: $0.13
Volume34,600 shs
Average VolumeN/A
Market Capitalization$11.09 million
P/E RatioN/A
Dividend YieldN/A
Pivot Pharmaceuticals, Inc. is a development stage biopharmaceutical company. It is engaged in the development and commercialization of therapeutic pharmaceutical products, with a strategic emphasis on the innovation of new therapeutic uses for existing drugs. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual SalesN/A
Book Value$0.03 per share


Net Income$-7,010,000.00


Market Cap$11.09 million
Next Earnings Date12/17/2019 (Estimated)
OptionableNot Optionable

Receive PVOTF News and Ratings via Email

Sign-up to receive the latest news and ratings for PVOTF and its competitors with MarketBeat's FREE daily newsletter.

Pivot Pharmaceuticals (OTCMKTS:PVOTF) Frequently Asked Questions

What is Pivot Pharmaceuticals' stock symbol?

Pivot Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PVOTF."

When is Pivot Pharmaceuticals' next earnings date?

Pivot Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, December 17th 2019. View Earnings Estimates for Pivot Pharmaceuticals.

Has Pivot Pharmaceuticals been receiving favorable news coverage?

News headlines about PVOTF stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pivot Pharmaceuticals earned a media sentiment score of -1.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Pivot Pharmaceuticals.

Who are some of Pivot Pharmaceuticals' key competitors?

What other stocks do shareholders of Pivot Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pivot Pharmaceuticals investors own include Peabody Energy (BTUUQ), Allena Pharmaceuticals (ALNA), Aurora Cannabis (ACBFF), InMed Pharmaceuticals (IMLFF), Canopy Growth (CGC), New York REIT (NYRT), Ampliphi Biosciences (APHB), Aphria (APHQF), Auxly Cannabis Group (CBWTF) and United Cannabis (CNAB).

Who are Pivot Pharmaceuticals' key executives?

Pivot Pharmaceuticals' management team includes the folowing people:
  • Joseph Borovsky, Chairman & Executive Vice President-Technology
  • Patrick Charles Frankham, President, CEO, Director & VP-Business Development
  • Moira Ong, Chief Financial Officer
  • Wolfgang Renz, Director & Chief Medical Officer

How do I buy shares of Pivot Pharmaceuticals?

Shares of PVOTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pivot Pharmaceuticals' stock price today?

One share of PVOTF stock can currently be purchased for approximately $0.13.

How big of a company is Pivot Pharmaceuticals?

Pivot Pharmaceuticals has a market capitalization of $11.09 million. View Additional Information About Pivot Pharmaceuticals.

What is Pivot Pharmaceuticals' official website?

The official website for Pivot Pharmaceuticals is http://pivotpharma.com/.

How can I contact Pivot Pharmaceuticals?

Pivot Pharmaceuticals' mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The company can be reached via phone at 604-805-7783.

MarketBeat Community Rating for Pivot Pharmaceuticals (OTCMKTS PVOTF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Pivot Pharmaceuticals and other stocks. Vote "Outperform" if you believe PVOTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PVOTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel